Fund Holdings — Commodore Capital LP

Total Portfolio Value:
$1.36B
Total Bought:
$320.18M
Total Sold:
$70.31M
Net Transaction:
+$249.88M
Notable People:
Michael Jonathan Kramarz, Robert Egen Turrell Atkinson, Commodore Capital Gp Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V3,874,1824,472,840+598,658$162.91M$188.26M13.87%+$25.35M
Nuvalent Inc1,621,6001,855,000+233,400$126.94M$131.56M9.69%+$4.62M
Enliven Therapeutics Inc4,205,0004,675,000+470,000$94.61M$92.00M6.78%-$2.61M
Soleno Therapeutics Inc1,525,0001,150,000-375,000$68.55M$82.17M6.05%+$13.62M
Xenon Pharmaceuticals Inc.(XENE)2,740,0002,325,000-415,000$107.41M$78.00M5.75%-$29.40M
Alkermes plcSHS(ALKS)2,300,0001,950,000-350,000$66.15M$64.39M4.74%-$1.76M
Agios Pharmaceuticals, Inc.(AGIO)02,185,000+2,185,000$0$64.02M4.72%+$64.02M
Vaxcyte, Inc.(PCVX)1,625,0001,650,000+25,000$133.02M$62.30M4.59%-$70.72M
Vera Therapeutics, Inc.CL A(VERA)1,958,6002,561,782+603,182$82.83M$61.53M4.53%-$21.30M
Celldex Therapeutics, Inc.(CLDX)03,200,000+3,200,000$0$58.08M4.28%+$58.08M
Scholar Rock Holding Corporation(SRRK)950,0001,745,000+795,000$41.06M$56.10M4.13%+$15.04M
Cogent Biosciences, Inc.(COGT)6,881,6298,892,816+2,011,187$53.68M$53.27M3.93%-$408.7K
Viridian Therapeutics, Inc.(VRDN)2,400,0003,600,000+1,200,000$46.01M$48.53M3.58%+$2.52M
Nurix Therapeutics, Inc.(NRIX)3,000,0003,978,907+978,907$56.52M$47.27M3.48%-$9.25M
Centessa Pharmaceuticals PlcADS2,218,4252,367,578+149,153$37.16M$34.05M2.51%-$3.11M
Spyre Therapeutics, Inc.(SYRE)1,988,0841,988,0840$46.28M$32.08M2.36%-$14.20M
Pharvaris N V
COM
1,911,4331,911,4330$36.64M$30.01M2.21%-$6.63M
Mind Medicine Mindmed Inc4,308,4254,525,000+216,575$29.99M$26.47M1.95%-$3.52M
Solid Biosciences Inc05,825,000+5,825,000$0$21.55M1.59%+$21.55M
Bright Minds Biosciences Inc.(DRUG)500,000500,0000$18.01M$18.04M1.33%+$25.0K
Cardiff Oncology, Inc.(CRDF)5,384,6165,384,6160$23.37M$16.91M1.25%-$6.46M
Oruka Therapeutics, Inc.(ORKA)1,419,7141,419,7140$27.53M$14.57M1.07%-$12.96M
Inhibikase Therapeutics, Inc.(IKT)5,925,0005,344,432-580,568$19.26M$11.70M0.86%-$7.55M
ORIC Pharmaceuticals, Inc.(ORIC)2,000,0002,000,0000$16.14M$11.16M0.82%-$4.98M
Apogee Therapeutics Inc290,000290,0000$13.14M$10.83M0.80%-$2.30M
Neurogene Inc.(NGNE)800,000925,000+125,000$18.29M$10.83M0.80%-$7.46M
Tyra Biosciences, Inc.(TYRA)0950,000+950,000$0$8.84M0.65%+$8.84M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.63M$7.72M0.57%+$90.0K
Celcuity Inc.(CELC)400,000695,650+295,650$5.24M$7.03M0.52%+$1.80M
Vistagen Therapeutics, Inc.(VTGN)1,575,0001,575,0000$4.65M$3.94M0.29%-$708.8K
Avalo Therapeutics, Inc.(AVTX)483,000483,0000$3.59M$3.87M0.29%+$280.1K
ABIVAX Société AnonymeADS(ABVX)1,284,1100-1,284,110$9.40M$0—-$9.40M
Helix Acquisition Corp IiCL A500,0000-500,000$5.25M$0—-$5.25M
Nkarta, Inc.(NKTX)351,8480-351,848$876.1K$0—-$876.1K
Third Harmonic Bio Inc237,7040-237,704$2.45M$0—-$2.45M
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q1 2025 | TickerTrail